Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cell|October 8, 2021
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironmentKhiem C Lam, Romina E Araya, April Huang, et al.
Cancer Discovery|March 27, 2012
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenibRyan B Corcoran, Hiromichi Ebi, Alexa B Turke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Immunity|June 23, 2016
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control AdenocarcinomaAvery D Posey, Robert D Schwab, Alina C Boesteanu, et al.
Molecular Therapy Oncolytics|October 12, 2018
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasYibo Yin, Alina C Boesteanu, Zev A Binder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Blood|January 28, 2016
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaJoseph A Fraietta, Kyle A Beckwith, Prachi R Patel, et al.
Science Translational Medicine|February 20, 2015
Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastomaLaura A Johnson, John Scholler, Takayuki Ohkuri, et al.
Pageof 3